SBFM SUNSHINE BIOPHARMA INC Management Changes 8-K Filing 2024 - Management Changes Sunshine Biopharma Inc. has amended employment agreements for its CEO, CFO, and COO, with salaries of $543,753 CAD, $411,000 CAD, and $328,800 CAD respectively, and severance payments of $14 million USD and $2 million CAD for termination without cause.Get access to all SEC 8-K filings of the SUNSHINE BIOPHARMA INC